AU2002221099A1 - Combination drugs - Google Patents

Combination drugs

Info

Publication number
AU2002221099A1
AU2002221099A1 AU2002221099A AU2109902A AU2002221099A1 AU 2002221099 A1 AU2002221099 A1 AU 2002221099A1 AU 2002221099 A AU2002221099 A AU 2002221099A AU 2109902 A AU2109902 A AU 2109902A AU 2002221099 A1 AU2002221099 A1 AU 2002221099A1
Authority
AU
Australia
Prior art keywords
combination drugs
drugs
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221099A
Inventor
Shohei Hashiguchi
Masayuki Ii
Yuji Iizawa
Tomoyuki Kitazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002221099A1 publication Critical patent/AU2002221099A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
AU2002221099A 2000-12-08 2001-12-07 Combination drugs Abandoned AU2002221099A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-379787 2000-12-08
JP2000379787 2000-12-08
PCT/JP2001/010773 WO2002045750A1 (en) 2000-12-08 2001-12-07 Combination drugs

Publications (1)

Publication Number Publication Date
AU2002221099A1 true AU2002221099A1 (en) 2002-06-18

Family

ID=18848088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221099A Abandoned AU2002221099A1 (en) 2000-12-08 2001-12-07 Combination drugs

Country Status (5)

Country Link
US (1) US20040063685A1 (en)
EP (1) EP1348443A4 (en)
AU (1) AU2002221099A1 (en)
CA (1) CA2431206C (en)
WO (1) WO2002045750A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1495756A4 (en) * 2002-04-08 2009-10-28 Takeda Pharmaceutical Severe sepsis preventive therapeutic agent
AU2005314133B2 (en) * 2004-12-06 2012-03-08 Medicinova, Inc. Ibudilast for treating neuropathic pain and associated syndromes
EP2131841B1 (en) * 2007-01-30 2012-08-01 Avigen, Inc. Methods for treating acute pain
US20080287402A1 (en) * 2007-05-03 2008-11-20 Johnson Kirk W Use of a glial attenuator to prevent amplified pain responses caused by glial priming
JP2011503104A (en) 2007-11-09 2011-01-27 カリフォルニア インスティテュート オブ テクノロジー Immunomodulatory compounds and related compositions and methods
EP2283159B1 (en) * 2008-05-05 2013-10-09 The Scripps Research Institute Synthesis of (+) cortistatin a and related compounds
WO2010098906A1 (en) * 2009-02-24 2010-09-02 Madeira Therapeutics Liquid statin formulations
EP2528598B1 (en) 2010-01-27 2016-01-13 Takeda Pharmaceutical Company Limited Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent
HUE040658T2 (en) 2010-04-07 2019-03-28 California Inst Of Techn Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
CA2800174A1 (en) 2010-05-20 2011-11-24 June L. Round Antigen specific tregs and related compositions, methods and systems
US20140357563A1 (en) * 2011-12-09 2014-12-04 The Children's Hospital Of Philadelphia Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof
WO2016201342A1 (en) * 2015-06-10 2016-12-15 California Institute Of Technology Sepsis treatment and related compositions methods and systems

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE171042T1 (en) * 1989-08-01 1998-10-15 Scripps Research Inst METHODS AND COMPOSITIONS FOR IMPROVING THE SYMPTOMS OF SEPSIS
GB8918232D0 (en) * 1989-08-10 1989-09-20 Opal Stephen M Pharmaceutical product for the treatment of septic shock
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
WO1996001115A1 (en) * 1994-07-01 1996-01-18 Pro-Neuron, Inc. Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
JP3693377B2 (en) * 1995-04-20 2005-09-07 森永乳業株式会社 Peptide mixture having infection-protecting action in vivo and composition containing this peptide mixture
ZA969721B (en) * 1995-11-21 1997-11-28 Smithkline Beecham Corp Method of treating sepsis.
US5753218A (en) * 1996-05-03 1998-05-19 Schering Corporation Method for treating inflammation
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
ES2202796T3 (en) * 1997-02-03 2004-04-01 Pfizer Products Inc. DERIVATIVES OF ARILSULFONYLAMINOHYDROXAMIC ACIDS.
ES2232114T3 (en) * 1998-03-09 2005-05-16 Takeda Pharmaceutical Company Limited CYCLAL ALKEN DERIVATIVES, PROCEDURE FOR PRODUCTION, AND USE.
DE60045033D1 (en) * 1999-08-06 2010-11-11 Takeda Pharmaceutical SUBSTITUTED AROMATIC RING COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE
WO2001056562A1 (en) * 2000-02-04 2001-08-09 Takeda Chemical Industries, Ltd. Stable emulsion compositions

Also Published As

Publication number Publication date
EP1348443A1 (en) 2003-10-01
US20040063685A1 (en) 2004-04-01
CA2431206A1 (en) 2002-06-13
CA2431206C (en) 2009-09-01
EP1348443A4 (en) 2005-07-06
WO2002045750A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001288294A1 (en) Anti-hypercholesterolemic drug combination
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001269508A1 (en) Drugs or cosmetics
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2002221099A1 (en) Combination drugs
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001232244A1 (en) Drug comprising combination
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001267135A1 (en) Medicaments